Jane Wasman
2012
In 2012, Jane Wasman earned a total compensation of $3.4M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 110% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $314,700 |
|---|---|
| Option Awards | $1,415,718 |
| Salary | $458,750 |
| Stock Awards | $1,252,290 |
| Other | $7,350 |
| Total | $3,448,808 |
Wasman received $1.4M in option awards, accounting for 41% of the total pay in 2012.
Wasman also received $314.7K in non-equity incentive plan, $458.8K in salary, $1.3M in stock awards and $7.4K in other compensation.
Rankings
In 2012, Jane Wasman's compensation ranked 1,968th out of 11,487 executives tracked by ExecPay. In other words, Wasman earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,968 out of 11,487 | 83rd |
Division Manufacturing | 697 out of 4,253 | 84th |
Major group Chemicals And Allied Products | 158 out of 1,198 | 87th |
Industry group Drugs | 90 out of 920 | 90th |
Industry Biological Products, Except Diagnostic Substances | 14 out of 160 | 91st |
Source: SEC filing on April 30, 2015.
Wasman's colleagues
We found four more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2012.